APOTHEEK MEEUSEN
ActiveSummary
APOTHEEK MEEUSEN has been active since 2001 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €735k and a net result of €126k. Equity is growing by ~7.5% per year across the filed fiscal years. Its solvency ranks better than 60% of 10359 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.5% (very low).
Checked score
Score 2025
73
/ 100
Healthy
The score weighs solvency, liquidity, profitability and financial development. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability79=
Solvency71▲+6
Growth78=
Track record100
Bankruptcy probability, 12 months
0.5%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €50k at 30 days acceptable
Liquidity ample (current ratio 1.54 against 1.37 in 2024; short-term debt: 25.6% and cash: 6% of total assets), but 53.9% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Four signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 47
Relative position
BE, all sectors
reference
Sector 47
higher
← fewer bankruptcies
more bankruptcies →
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
46.1%
Return on assets
7.9%
Age of the figures
9 mo
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 29-05-2026, 63 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
63 d early
2024
93 d early
2023
98 d early
2022
56 d early
2021
59 d early
2020
on the day
2019
20 d late
← before the deadline
after the deadline →
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
24-09-2026 today31-12-2026 close31-07-2027 deadline
Financials · fiscal year 2025, abbreviated schema
Source amounts without an identifiable currency are assumed to be EUR.
Equity
€735k▲ 19.5%
2024 · €615k
2018: €468k
2019: €414k
2020: €414k
2021: €300k
2022: €396k
2023: €493k
2024: €615k
2018 → 2025
Total assets
€1.60M▲ 3.7%
2024 · €1.54M
2018: €904k
2019: €1.48M
2020: €1.62M
2021: €1.51M
2022: €1.50M
2023: €1.48M
2024: €1.54M
2018 → 2025
Net result
€126k▼ 0.8%
2024 · €127k
2018: €-64k
2019: €160k
2020: €160k
2021: €91k
2022: €103k
2023: €101k
2024: €127k
2018 → 2025
Working capital
€220k▲ 32.1%
2024 · €166k
2018: €533k
2019: €512k
2020: €348k
2021: €2k
2022: €30k
2023: €76k
2024: €166k
2018 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20212022202320242025Trend
Equity€300k-€396k▲ 32.1%€493k▲ 24.3%€615k▲ 24.8%€735k▲ 19.5%
Operating result€157k-€173k▲ 10.3%€175k▲ 1.1%€206k▲ 17.6%€203k▼ 1.5%
Net result€91k-€103k▲ 12.6%€101k▼ 1.8%€127k▲ 26.4%€126k▼ 0.8%
Turnover and EBIT margin not published: the abbreviated schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result falls in 2025; 2025 is 2% below 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €1.60M
Fixed assets
€967k ▲ 4.3%
Current assets
€628k ▲ 2.7%
Equity and liabilities €1.60M
Equity
€735k ▲ 19.5%
Debt
€860k ▼ 6.9%
Debt's share of the balance-sheet total falls from 60.0% to 53.9%. Equity is higher and debt is lower.
Key figures and ratios
EBITDA
€272k▼
2024 · €276k
Cash flow
€195k▼
2024 · €197k
Current ratio
1.54▲
2024 · 1.37
Quick ratio
0.70▼
2024 · 0.71
Debt to equity
1.17▼
2024 · 1.50
ROE
17.2%▼
2024 · 20.7%
ROA
7.9%▼
2024 · 8.3%
Interest coverage
7.06▼
2024 · 7.36
Debt ≤ 1 year
€408k▼
2024 · €445k
Debt > 1 year
€451k▼
2024 · €478k
Income taxes
€41k▼
2024 · €44k
Staff costs
€157k▲
2024 · €141k
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Filed annual accounts As filed with the NBB · 2025 against 2024 · 58 lines
Balance sheet
Code20242025
Assets
Total assets20/58€1.54M€1.60M▲
Fixed assets21/28€928k€967k▲
Intangible fixed assets21€13k€11k▼
Tangible fixed assets22/27€910k€951k▲
Land and buildings22€839k€798k▼
Plant, machinery and equipment23€65k€145k▲
Furniture and vehicles24€6k€9k▲
Financial fixed assets28€5k€5k=
Current assets29/58€611k€628k▲
Stocks and contracts in progress3€296k€342k▲
Stocks30/36€296k€342k▲
Amounts receivable within one year40/41€178k€166k▼
Trade receivables40€178k€166k▼
Other amounts receivable41€82-
Cash at bank and in hand54/58€109k€96k▼
Deferred charges and accrued income490/1€29k€24k▼
Equity and liabilities
Total equity and liabilities10/49€1.54M€1.60M▲
Equity10/15€615k€735k▲
Contributions10/11€19k€19k=
Reserves13€565k€685k▲
Distributable reserves133€565k€685k▲
Profit (loss) carried forward14€2k€4k▲
Investment grants15€29k€28k▼
Amounts payable17/49€924k€860k▼
Amounts payable after more than one year17€478k€451k▼
Financial debts170/4€478k€451k▼
Amounts payable within one year42/48€445k€408k▼
Current portion of amounts payable after more than one year42€94k€85k▼
Financial debts43€12k€12k▲
Credit institutions430/8€12k€12k▲
Trade debts44€136k€166k▲
Suppliers440/4€136k€166k▲
Taxes, remuneration and social security45€27k€29k▲
Taxes450/3€11k€7k▼
Remuneration and social security454/9€16k€22k▲
Other amounts payable47/48€177k€116k▼
Accrued charges and deferred income492/3€637€1k▲
Income statement
Code20242025
Remuneration, social security and pensions62€141k€157k▲
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€69k€69k▼
Other operating charges640/8€6k€7k▲
Non-recurring operating charges66A€6k-
Gross operating margin9900€429k€436k▲
Operating profit (loss)9901€206k€203k▼
Financial income75/76B€3k€3k▼
Recurring financial income75€3k€3k▼
Financial charges65/66B€37k€39k▲
Recurring financial charges65€37k€39k▲
Profit (loss) for the period before taxes9903€172k€167k▼
Income taxes67/77€44k€41k▼
Profit (loss) for the period9904€127k€126k▼
Profit (loss) for the period to be appropriated9905€127k€126k▼
Appropriation of the result
Profit (loss) to be appropriated9906€146k€129k▼
Profit (loss) brought forward from the previous period14P€19k€2k▼
Transfer to equity691/2€140k€120k▼
To other reserves6921€140k€120k▼
Profit to be distributed694/7€4k€5k▲
Employees696€4k€5k▲
Social balance
Average headcount (FTE)90872.42.2▼
The notes to these accounts (14 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
29-05
NBB filing
Annual accounts filed
fiscal year 2025 · abbreviated schema
2025
29-04
NBB filing
Annual accounts filed
fiscal year 2024 · abbreviated schema
2024
31-12
Financial
Equity above €500kEq €615k ▲24.8%
6 profitable years in a row build equity to €615k.
24-04
NBB filing
Annual accounts filed
fiscal year 2023 · abbreviated schema
2023
05-06
NBB filing
Annual accounts filed
fiscal year 2022 · abbreviated schema
2022
02-06
NBB filing
Annual accounts filed
fiscal year 2021 · abbreviated schema
2021
31-07
NBB filing
Annual accounts filed
fiscal year 2020 · abbreviated schema
2020
20-08
NBB filing
Annual accounts filed
fiscal year 2019 · abbreviated schema · 20 days late
2019
31-12
Financial
Back to profitnet €160k
Net result €160k after one loss-making year.
02-08
NBB filing
Annual accounts filed
fiscal year 2018 · abbreviated schema · 2 days late
2018
25-06
NBB filing
Annual accounts filed
fiscal year 2017 · abbreviated schema
2017
03-08
NBB filing
Annual accounts filed
fiscal year 2016 · abbreviated schema · 3 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
4 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Beerse · 1 establishment unit since 2001
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Oostmalseweg 102 A2340 BeerseGround area
1,430 m²
Building footprint
224 m²
Volume, LiDAR
1,212 m³
Parcel 13004E0001/00X061, Flanders · tallest building 7.2 m, ±2 floors. Linked by address, not a title deed.
1 establishment unit
Apotheek Meeusen
since 20012.131.486.215
1 parcel
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 13004E0001/00X061 | Flanders | 1,430 m² | 1 · 224 m² | 7.2 m · 2 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Public money · subsidies and aid
Flemish government
2022 · 1 entry · 99 EUR awarded · 99 EUR paid| Year | Entries | awarded | paid |
|---|---|---|---|
| 2022 | 1 | 99 EUR | 99 EUR |
Schemes
Subsidie voor opleiding en advies voor kmo's en zelfstandigen (kmo-portefeuille)
Recognitions · licences · registrations
Food safety, FASFC
1 siteBeerse2.131.486.215
Similar companies · same sector, comparable size
PHARMACIE GAYE Saint-Cosme
BE 0438.978.646
Chimay · Eq €735,468
APOTHEEK DE SCHRIJVER
BE 0437.172.862
Rijkevorsel · Eq €735,519
APOTHEEK TWEE NETEN
BE 0461.936.764
Lier · Eq €734,464
APOTHEEK HEYLEN
BE 0414.011.935
Nijlen · Eq €735,700
Apotheek VAN der ELST Filip
BE 0442.717.797
Geraardsbergen · Eq €736,336
Of 5,220 companies in sector 47730 we hold annual accounts for 3,861. 3,202 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded19-09-2001
Fiscal year end31-12
Activities, NACEBEL 2025
47730Retail sale of pharmaceutical products
47741Retail sale of medical and orthopaedic goods, excluding prescription glasses and lenses
Sources
Crossroads Bank for EnterprisesNational Bank · 24 filingsAddress and cadastre registers
Scores and ratios are computed by Checked and are not a credit decision.